Skip to content

Clinical trials

Completed Acute Coronary Syndrome trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Status: Completed Country / region: Taiwan Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20093
20102
20111
20142
20182
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Eli Lilly and Company2
GlaxoSmithKline2
Sanofi2
CSL Behring1
Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company1
Far Eastern Memorial Hospital1
Janssen Research & Development, LLC1
National Taiwan University Hospital1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome14
Cardiovascular Diseases3
Coronary Artery Disease3
Myocardial Infarction3
Angina, Unstable2
Atherosclerosis2
Coronary Disease2
Heart Diseases2
ST Elevation Myocardial Infarction2
Stroke2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.